Johnson & Johnson Innovative Medicine · 5 hours ago
Manager 1, Projects Clinical Operations
Johnson & Johnson Innovative Medicine is focused on healthcare innovation to improve health outcomes. They are seeking an innovation leader to drive clinical trial experience improvements through agile projects and cross-functional collaboration.
Pharmaceuticals
Responsibilities
Design and execute agile innovation demonstration projects to evaluate effectiveness, viability and return on investment. These projects will identify and test novel approaches, processes, technologies and best practices that will create value for patients, have the potential to optimize trial recruitment, reduce trial set up and execution cycle times, and/or reduce cost
Collaborate with internal and external cross-functional teams to validate hypotheses
Collaborate with cross-functional teams to execute the projects, develop project plans, set milestones, and monitor progress to ensure timely evaluation and decision making for launch
Generate conclusive results to support the business case for launch or adoption of these new methods
Proactively identifying potential roadblocks and taking a solutions-driven approach for complex and undefined projects that may not be addressed by existing policies, procedures, or protocols
Providing leadership and project management for multiple initiatives simultaneously. Support IH Launch, with change management to ensure successful implementation in the broader organization
Qualification
Required
A Bachelors' degree is required
A minimum of 4 or more years of work experience (industry or academia) is required
A minimum of 3 years of experience in a clinical development environment (pharmaceutical, medical devices, CRO or other clinical development service organization)
Preferred
Master's degree/Graduate degree in business or life sciences
Company
Johnson & Johnson Innovative Medicine
Johnson and Johnson Innovative Medicine focuses on developing medical solutions for some of the challenging diseases and medical conditions.
Funding
Current Stage
Late StageRecent News
2025-08-14
Company data provided by crunchbase